| Company | Date | Position | Consensus ⓘ | Price Target ⓘ | 1-Yr Return | vs S&P 500 ⓘ |
|---|---|---|---|---|---|---|
|
ICUI
ICU Medical
|
Aug 07, 2026 | BUY |
Strong Buy
-3.7% avg upside
9 analysts
|
$200.00
8.37% Upside
|
+0.0% | · |
|
TFX
Teleflex
|
Aug 07, 2026 | BUY |
Buy
+38.2% avg upside
20 analysts
|
$155.00
14.91% Upside
|
+0.0% | · |
|
SYK
Stryker
|
Jul 31, 2026 | BUY |
Strong Buy
+8.6% avg upside
37 analysts
|
$370.00
9.20% Upside
|
+4.1% | · |
|
MMSI
Merit Medical Systems
|
Jul 31, 2026 | BUY |
Strong Buy
+11.0% avg upside
15 analysts
|
$100.00
12.36% Upside
|
+4.7% | · |
|
DXCM
Dexcom
|
Jul 31, 2026 | BUY |
Strong Buy
+23.5% avg upside
32 analysts
|
$94.00
10.97% Upside
|
+1.6% | · |
|
ABT
Abbott Laboratories
|
Jul 17, 2026 | BUY |
Strong Buy
+6.9% avg upside
36 analysts
|
— | +7.1% | · |
|
ISRG
Intuitive Surgical
|
Jul 17, 2026 | BUY |
Strong Buy
+26.6% avg upside
36 analysts
|
$483.00
27.44% Upside
|
+9.7% | · |
|
JNJ
Johnson & Johnson
|
Jul 16, 2026 | BUY |
Strong Buy
-9.0% avg upside
39 analysts
|
$265.00
2.23% Upside
|
+3.7% | · |
|
PODD
Insulet
|
Jun 08, 2026 | BUY |
Strong Buy
+54.0% avg upside
32 analysts
|
$216.00
53.02% Upside
|
-12.1% | · |
|
AXGN
AxoGen
|
Apr 29, 2026 | BUY |
Strong Buy
-24.2% avg upside
21 analysts
|
$48.00
3.39% Upside
|
+11.2% | · |
|
BSX
Boston Scientific
|
Mar 27, 2026 | BUY |
Strong Buy
+37.4% avg upside
38 analysts
|
$88.00
78.41% Upside
|
-28.7% | · |
|
ZBH
Zimmer Biomet Holdings
|
Jan 06, 2026 | HOLD |
Buy
+17.4% avg upside
38 analysts
|
— | +2.5% | · |
|
EW
Edwards Lifesciences
|
Nov 03, 2025 | BUY |
Strong Buy
+11.9% avg upside
34 analysts
|
$96.00
7.09% Upside
|
+8.0% | · |
|
CBLL
Ceribell, Inc.
|
Oct 20, 2025 | BUY |
Strong Buy
+33.0% avg upside
8 analysts
|
$19.00
1.06% Upside
|
+46.0% | · |
|
MDT
Medtronic
|
Aug 18, 2025 | HOLD |
Buy
+10.6% avg upside
38 analysts
|
— | -3.0% | · |
|
SENS
Senseonics Holdings
|
Aug 08, 2025 | SELL |
Buy
+113.0% avg upside
13 analysts
|
— | +29.1% | · |
|
IART
Integra Lifesciences
|
Aug 01, 2025 | HOLD |
Buy
+151.6% avg upside
21 analysts
|
— | +35.3% | · |
|
BAX
Baxter International
|
Aug 01, 2025 | HOLD |
Buy
+21.5% avg upside
23 analysts
|
— | +20.2% | · |
|
BDX
Becton Dickinson
|
May 02, 2025 | HOLD |
Buy
+10.2% avg upside
25 analysts
|
— | +15.2% | · |
|
BWAY
Brainsway
|
Nov 16, 2023 | HOLD |
Strong Buy
-11.3% avg upside
10 analysts
|
— | +95.3% | · |
|
TNDM
Tandem Diabetes Care
|
May 04, 2023 | HOLD |
Buy
+46.9% avg upside
29 analysts
|
— | +19.2% | · |
|
ANGO
AngioDynamics
|
Apr 17, 2023 | BUY |
Strong Buy
+13.3% avg upside
9 analysts
|
$13.00
17.09% Downside
|
-30.3% | · |
|
VIVE
Viveve Medical
|
Jul 23, 2019 | HOLD |
Buy
+79999900.0% avg upside
8 analysts
|
— | · | · |
Disclaimer: 13Foresight compiles analyst ratings and price targets from publicly available sources. Performance metrics, rankings and star ratings shown here are calculated independently by 13Foresight from historical market prices and may differ from figures published elsewhere. This information may be incomplete, delayed or inaccurate, is provided for research and informational purposes only, and is not investment advice. The underlying ratings and opinions are those of the respective analysts and their firms; 13Foresight accepts no liability for any decisions made based on this data.